DAX®15.234,16+0,21%TecDAX®3.483,12+0,22%Dow Jones 3033.800,60+0,89%Nasdaq 10013.845,05+0,63%

PRESS RELEASE: 4finance S.A.: 4finance report on FY 2020 unaudited results

| Quelle: Dow Jones Newsw... | Lesedauer etwa 6 min. | Text vorlesen Stop Pause Fortsetzen

DGAP-News: 4finance S.A. / Key word(s): Quarterly / Interim Statement
4finance S.A.: 4finance report on FY 2020 unaudited results
2021-02-26 / 12:40
The issuer is solely responsible for the content of this announcement.
Proactive business response to Covid-19, providing continuous service to customers throughout 2020.
Strong performance from TBI Bank. Online business re-focused on core products & markets.
Solid capital and liquidity position with no maturities in 2021.

26 February 2021. 4finance Holding S.A. (the 'Group' or '4finance'), one of Europe's largest digital consumer lending
groups, today announces unaudited consolidated results for the twelve months ending 31 December 2020 (the 'Period').

Operational Highlights
- Strong customer repayment dynamics observed since the summer enabled underwriting criteria and acceptance rates to be
restored close to normal levels for new and existing customers in most products during H2 2020.
- Proactive operational response to Covid-19 throughout the year enabled continuous service to customers and market
share gains in some countries.
- Support made available for customers whose finances have been disrupted, with early and proactive measures including
discounted or free payment deferrals. Regulatory-driven programmes now largely finished, with no adverse effect seen in
performance of customers coming out of payment deferral periods in relevant markets (Czech Republic and TBI Bank)
compared to the rest of the portfolio.
- Subprime loan issuance in Q4 was slightly up on Q3, with issuance volumes of continuing products reaching pre-Covid
levels. However the market-wide demand for credit remains subdued, particularly since the reinstatement of 'lockdowns'
in many markets towards the end of the year. Investment in marketing remains quite selective in this environment.
- Near-prime portfolio growth continues in Lithuania, Latvia and Denmark, with issuance in the Period up 9%
year-on-year (25% in the online business and 7% in TBI Bank) reflecting strong customer demand and the expanded product
range. Issuance levels in 2021 will be closely linked to ability to fund via TBI Bank.
- TBI Bank loan issuance volume during the Period grew by 4% year-on-year to EUR349.8 million from EUR336.7 million in the
prior year period, with increased issuance in the third and fourth quarters in all products.

Financial Highlights
- Interest income of EUR307.9 million in the Period, down 28% from EUR424.9 million in the prior year period. The
significant reduction in online loan issuance in the spring due to Covid-19 resulted in a lower level of interest
income, although issuance and income from continuing products recovered somewhat post summer. Product and market exits
have counterbalanced this, so interest income has been similar from Q2 to Q4 at just over EUR70 million per quarter.
- Cost to income ratio for the Period was 56.9%, vs. 51.3% in 2019, due to the lower interest income, despite bringing
down operating costs down 21% year-on-year. Costs were reduced in each quarter of the year, reflecting cost discipline
across the Group, the reduction of marketing spend and savings in personnel costs.
- Adjusted EBITDA was EUR75.1 million for the Period, down 39% year-on-year. The full interest coverage ratio as of the
date of this report is 1.8x. The Q4 quarterly EBITDA contribution of EUR23.1 million was up significantly from Q2 and Q3.
- Post-provision operating profit for the Period was EUR21.8 million, with a loss before tax of EUR0.3 million.
- Net receivables totaled EUR526.4 million as of 31 December 2020, down 9.1% year-to-date. During the fourth quarter, TBI
Bank grew net receivables further and the small reduction in online business portfolio was due to run-off products.
- Overall gross NPL ratio at 17.0% as of 31 December 2020 (19.2% for online), compared with 20.7% as of 31 December
2019 (24.9% for online). The resumption of debt sales in most markets in the autumn drove the significant reduction in
NPL ratio during the third and fourth quarters. Online NPL ratio helped by increased proportion of near-prime loans.
- Overall cost of risk was 14.2% for the Period, improved from 17.1% in 2019. For the online business it was 24.2% for
the Period, compared to 27.5% in 2019, and in TBI Bank it was 6.1% for the Period, compared to 4.6% in 2019.
- Strong funding position, with EUR80.5 million of online cash at the end of the Period and no debt maturities until
2022, and solid liquidity and capital adequacy at TBI Bank.

Strategic Highlights
- Refocusing online business on core seven markets and products where the Group's strong brands and experience can
deliver superior unit economics.
- At the end of 2020, the near-prime segment (including TBI Bank consumer and online) represented 62% of net
receivables, up from 48% at the end of 2019. Single payment loans represent only 13% of the Group's net receivables.
- TBI Bank performed well throughout 2020, with its strong points-of-sale relationships and market leading digital
options helping to grow consumer loan issuance volumes in Q4. However given the regulatory environment, the Group does
not expect dividends from TBI to resume until H2 2021 at the earliest.
- Good progress on efficient wind-down of exit markets. Further effort to simplify corporate structure by reducing
number of legal entities initiated in December.
- Costs were further reviewed across the Group in Q4 alongside budgeting process, with a focus on efficiency and
ensuring our operating approach is consistent with the reduced footprint. Lower cost base going into 2021.
- Closer cooperation with TBI Bank to develop near-prime lending across the business. Initial sales of Lithuanian
near-prime loans to TBI Bank planned in March following receipt of formal lending passport in mid February.

Kieran Donnelly, CEO of 4finance, commented:
"We're seeing the results of a sharper focus, a resilient business model and a return to normality in terms of borrower
behaviour. The actions we are taking to right-size our cost base and focus on seven markets with the best return on
investment are delivering results.
"Our leaner, more efficient team is optimising our subprime business and developing near-prime in lock-step with TBI
Bank and the funding opportunities it presents.
"Strong liquidity, improving NPL ratios in our online business, and continued growth at TBI Bank set us up to take
advantage of the emerging recovery and put us in a strong position to grow our share as other providers leave the
Contact: James Etherington, Group Chief Financial Officer
Email: james.etherington@4finance.com / investorrelations@4finance.com
Website: www.4finance.com

2021-02-26 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English
Company: 4finance S.A.
8-10 Avenue de la Gare
1610 Luxembourg
Grand Duchy of Luxembourg
E-mail: info@4finance.com
ISIN: XS1417876163, SE0006594412, XS1092320099, XS1094137806,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1171552

End of News DGAP News Service

1171552 2021-02-26

END) Dow Jones Newswires

February 26, 2021 06:41 ET ( 11:41 GMT)

Das könnte Sie auch interessieren

Weitere Nachrichten

Quelle: Dow Jones Newswire Web
10.04. PTA-News: Medigene AG: Identifizierung von zehn neuartigen Tumor-spezifischen Antigenen, die T-Zell-Immunreaktionen auslösen können - Poster-Präsentation auf dem virtuellen AACR Annual Meeting, 10.-15. April 2021 Medigene AG 3,89 +1,56%
10.04. PTA-News: Medigene AG: AACR-Daten zeigen Eigenschaften von Medigenes führendem TCR-Kandidaten gegen solide Tumore - Poster-Präsentation auf dem virtuellen AACR Annual Meeting, 10.-15. April 2021 Medigene AG 3,89 +1,56%
10.04. Bayer-Krebsmittel in Kombination bei Lymphomen sehr wirksam BAYER ADR /1/4 13,60 +0,74%
10.04. Bouffier gibt Laschet und Söder eine Woche zur Entscheidung
10.04. IPO/Biotech-Startup Vaccitech beantragt US-Börsengang AstraZeneca plc 83,44 -0,77%
10.04. Brüssel sendet Kompromisssignal im Zollstreit mit den USA
10.04. Scholz fordert Testpflicht für Unternehmen
10.04. Freenet verspricht künftig "hohe Ausschüttung" freenet AG 20,32 -0,05%
10.04. Sachsen-Anhalts CDU-Chef fordert Klärung der K-Frage binnen zwei Wochen
10.04. HINWEIS/Abkürzungen bei Dow Jones Newswires Deutschland
Rubrik: Finanzmarkt
10.04. MEDIEN/BVB-Interesse an Boateng?: Dortmund denkt über Transfer nach
10.04. Lehrerverband fordert Nachschärfung der Corona-Notbremse
10.04. Knauff wahrt Dortmunds Mini-Chance: 3:2-Sieg in Stuttgart
10.04. ROUNDUP 2/Kreise: Bund macht Vorschlag für Corona-Gesetz - Ausgangsbeschränkung
10.04. ROUNDUP: Scholz hofft nach «Endspurt» auf mögliche Corona-Öffnungen
10.04. ROUNDUP: Kretschmann schimpft über 'Einheitswahn' in der Corona-Politik
10.04. ROUNDUP: Protest in mehreren Städten für 'Zero-Covid'-Strategie
10.04. Weiter Ringen um einheitliche Regeln gegen dritte Corona-Welle
10.04. FDP bewertet bundesgesetzliche Corona-Notbremse 'äußerst kritisch'
10.04. Berlins Bürgermeister Müller sieht komplette nächtliche Ausgangssperre kritisch



Aktuelle Videos

HSBC Trading TV



Börsen & Märkte


zur Mediathek

Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Wie, glauben Sie, wird der DAX am Ende dieser Woche - KW 15 - stehen?
Jetzt abstimmen!
Alle Umfragen ansehen